- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03138382
Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
There is a growing realization that obesity can, in many ways, be viewed as a neurological disease triggered by lifestyle factors. There is clear evidence that the central melanocortin system, which is centered in the arcuate nucleus of the hypothalamus, regulates a "set-point" for how much fat the body should have. It does so by altering appetite and metabolic rate so that deviations too far in either direction are strongly resisted. This set-point is determined by genetic, epigenetic and lifestyle factors. Thus, excessive exposure to dietary monosaccharides, such as glucose, and saturated fats, especially in childhood and adolescence, can damage the neurons of the arcuate nucleus and push the set-point up. This then can condemn sufferers to a lifetime of obesity, despite individual efforts to combat it using diet and/or exercise.
Establishing a method of tuning down the set-point for body fat thus has to be a goal if the current obesity pandemic is to be successfully combatted. A significant amount of animal work suggests that stimulating the vestibular system in the inner ear, by means of chronic centrifugation, actually does just that and causes a reduction in body fat. This is likely because chronic vestibular activation is taken by the brain to represent a state of increased physical activity, and in order to optimize homeostasis it would be appropriate for the body to have a leaner physique, by reducing unnecessary energy expenditure from carrying excess fat.
It is possible to stimulate the vestibular nerve in humans by applying a small electrical current to the skin behind the ears. This is an established technology that is believed to be safe, but only previously used for research purposes. The investigators found in a pilot study that recurrent stimulation of this kind for two or three hours a week over four months led to a statistically significant reduction in truncal fat in the active group as opposed to the control group who underwent sham stimulation.
Given the current, and increasing levels of global obesity, it is important to determine whether non-invasive electrical vestibular nerve stimulation (VeNS), otherwise known as galvanic vestibular stimulation (GVS), is a viable treatment option, since if it were this would be of significant scientific importance.
The investigators wish to use the technique of indirect calorimetry to explore this. This involves wearing a tight face mask to collect all inspired oxygen and expired carbon dioxide and using formulae to calculate total energy expenditure and the component of metabolism that is derived from fat as compared to carbohydrate.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
California
-
San Diego, California, Vereinigte Staaten, 92093
- UC San Diego
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Signed informed consent
- Body mass index (BMI) > 25 kg/m2
- 18-65 years of age inclusive on starting the study.
- Successfully completed the screening questionnaire.
Exclusion Criteria:
- History of vestibular dysfunction.
- History of bariatric surgery, fundoplication, gastric resection or major upper-abdominal surgery (acceptable surgeries include cholecystectomy, hysterectomy).
- History of skin breakdown, eczema or other dermatological condition (e.g. psoriasis) affecting the skin behind the ears, or of the head and neck.
- History of weight loss device implantation (e.g. VBloc Maestro or Abiliti).
- Positive response in Physical Activity Readiness Questionnaire.
- Currently taking medication for asthma or other breathing conditions.
- Untreated thyroid disorder (stable treatment for 3 months is acceptable).
- Other endocrinological causes of weight gain (e.g. Cushing's disease, Cushing's syndrome or acromegaly)
- Previous diagnosis of HIV infection or AIDS (HIV is known to cause a vestibular neuropathy which would prevent VeNS from working).
- History of cirrhosis, or liver, kidney or heart failure.
- Chronic pancreatitis.
- Treatment with prescription weight-loss drug therapy in the year before starting the study.
- Tobacco or marijuana smoking in the 6 months prior to study.
- Known genetic cause of obesity (e.g., Prader-Willi Syndrome).
- Diabetes mellitus (Types 1 & 2).
- Diagnosis of epilepsy or use of anti-epileptic medication within six months of starting the study (e.g. for the treatment of peripheral neuropathy)
- Chronic (more than a month of daily use) treatment with opioid analgesic drugs within the last year.
- Regular use (more than twice a month) of anti-histamine medication.
- Use of oral or intravenous corticosteroid medication within two years of starting the study.
- Use of the beta-blockers atenolol, metoprolol or propranolol within 3 months of starting the study.
- Current use of tricyclic antidepressant medication for whatever reason.
- Current alterations in treatment regimens of anti-depressant medication for whatever reason (other than tricyclic antidepressants) (Note: stable treatment regimen for prior six months acceptable).
- An active diagnosis of cancer.
- A previous myocardial infarction.
- A history of stroke or severe head injury (as defined by a head injury that required intensive care). (In case this damaged the neurological pathways involved in vestibular stimulation).
- Presence of permanently implanted battery powered medical device or stimulator (e.g., pacemaker, implanted defibrillator, deep brain stimulator, vagal nerve stimulator etc.).
- Psychiatric disorders (including untreated severe depression, schizophrenia, substance abuse, bulimia nervosa etc.)
- Current participant in a clinical trial for weight loss.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Treatment then sham
20 subjects will be randomised to first receive active vestibular nerve stimulation during indirect calorimetry.
Then 2 weeks later they will return for sham stimulation during indirect calorimetry.
|
Electrical stimulation of the vestibular nerve with vestibular nerve stimulator (GVS device) for for 45 minutes using binaural mastoid placement.
Looks identical to vestibular nerve stimulator but discharges current into an internal resistor rather than activating the vestibular nerves.
|
Experimental: Sham then treatment
20 subjects will be randomised to first receive sham stimulation during indirect calorimetry.
Then 2 weeks later they will return for active vestibular nerve stimulation during indirect calorimetry.
|
Electrical stimulation of the vestibular nerve with vestibular nerve stimulator (GVS device) for for 45 minutes using binaural mastoid placement.
Looks identical to vestibular nerve stimulator but discharges current into an internal resistor rather than activating the vestibular nerves.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Fat Consumption (During VeNS)
Zeitfenster: During middle 15 minutes of 45 minute vestibular nerve stimulation session
|
Change in percent fat utilization from baseline as measured using indirect calorimetry.
|
During middle 15 minutes of 45 minute vestibular nerve stimulation session
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in Energy Expenditure (During VeNS)
Zeitfenster: During middle 15 minutes of 45 minute vestibular nerve stimulation session
|
Change in energy expenditure from baseline in kcal/min as measured using indirect calorimetry.
|
During middle 15 minutes of 45 minute vestibular nerve stimulation session
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 170798
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Vestibular Nerve Stimulator
-
Mayo ClinicAbgeschlossenErmüdung | Kopfschmerzen | Post-COVID-SyndromVereinigte Staaten
-
Oslo University HospitalUniversitaire Ziekenhuizen KU Leuven; Rigshospitalet, Denmark; Tampere University... und andere MitarbeiterBeendet
-
Austin HealthUniversity of Melbourne; Bionics Institute; Florey Institute of Neuroscience and... und andere MitarbeiterRekrutierung
-
Bahçeşehir UniversityAbgeschlossenFibromyalgie | Myofasziales SchmerzsyndromTruthahn
-
China Academy of Chinese Medical SciencesBeijing Tiantan Hospital; Beijing Children's HospitalUnbekannt
-
Leiden University Medical CenterElectroCore INC; Netherlands Organisation for Scientific ResearchRekrutierungIschämischer SchlaganfallNiederlande
-
Nu Eyne Co., Ltd.AbgeschlossenTinnitusKorea, Republik von
-
Christopher Hartnick, M.D.University of Pittsburgh; Emory University; Children's Hospital Medical Center... und andere MitarbeiterAbgeschlossenSchlafapnoe, obstruktiv | Down-SyndromVereinigte Staaten
-
Beijing Pins Medical Co., LtdUnbekanntEpileptische EnzephalopathieChina
-
Restorbio Inc.Beendet